These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 5515012)

  • 1. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the clinico-metabolic effects of administration of an association of rauwolfia, vasoactive drugs and hydroflumethiazide in a group of hypertensive patients].
    Pupita F; Piccioli R
    Policlinico Med; 1971; 78(5):229-37. PubMed ID: 4399831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cerebral blood-flow-volume in patients with sclerotic changes after treatment with raubasin (Lamuran)].
    Klemm J; Scheuring HJ
    Med Klin; 1974 May; 69(21):947-52. PubMed ID: 4602944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peripheral hemodynamic criteria and blood flow stimulating vasoactive drugs in healthy persons and in patients with arterial obstruction of the extremities].
    Ehringer H
    Med Welt; 1969 Jan; 3():148-60. PubMed ID: 5764800
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of patients with some rhythm disorders of the heart with N-propyl-aimaline-bromide].
    Gandzha IM; Radzivil VF
    Vrach Delo; 1972 May; 5():76-81. PubMed ID: 4112968
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of vasodilator drugs in occlusive vascular disease by measurement.
    Gillespie JA
    Angiology; 1966 May; 17(5):280-8. PubMed ID: 5936944
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertension with Detensitral. A therapeutic principle for general practice].
    Buchalik M
    Z Allgemeinmed; 1971 Oct; 47(30):1590-3. PubMed ID: 4399684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of hypertension].
    Schneider KW
    Med Monatsschr; 1973 Apr; 27(4):148-57. PubMed ID: 4145393
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations with a new combination of peripheral vasodilating agents].
    Dameno G
    Minerva Cardioangiol; 1967 Mar; 15(5):357-9. PubMed ID: 5603842
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 15. [New chemical substances for therapeutic use].
    Clin Ter; 1970 Mar; 52(6):571-4. PubMed ID: 5452999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiopathology and therapy of obliterating arteriopathies].
    Schettler G; Mörl H
    Clin Ter; 1979 Jan; 88(1):3-19. PubMed ID: 436376
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
    Brembach H
    Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.